RAYMOND JAMES & ASSOCIATES - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 151 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.5%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$417,000
-74.2%
7,801
-43.1%
0.00%
-85.7%
Q3 2015$1,614,000
+104.3%
13,711
+34.3%
0.01%
+133.3%
Q2 2015$790,000
+35.3%
10,208
+1.2%
0.00%0.0%
Q1 2015$584,000
+75.9%
10,089
-2.1%
0.00%
+50.0%
Q4 2014$332,00010,3030.00%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$125,702,00041.75%
VHCP Management, LLC 1,178,474$138,718,00035.56%
Palo Alto Investors LP 2,579,154$303,592,00014.60%
Baker Brothers Advisors 4,135,412$486,779,0004.50%
APIS CAPITAL ADVISORS, LLC 23,000$2,708,0003.75%
EMORY UNIVERSITY 11,096$1,306,0003.64%
Atika Capital Management LLC 61,000$7,180,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 488,912$57,550,0002.78%
Segantii Capital Management Ltd 100,000$11,134,0002.55%
NEXT CENTURY GROWTH INVESTORS LLC 428,835$50,478,0002.10%
View complete list of ANACOR PHARMACEUTICALS INC shareholders